Viewing Study NCT03709316


Ignite Creation Date: 2025-12-26 @ 11:47 AM
Ignite Modification Date: 2026-02-28 @ 6:47 PM
Study NCT ID: NCT03709316
Status: UNKNOWN
Last Update Posted: 2021-06-02
First Post: 2018-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ZL-2306-004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators